Bought
Maintained
Sold
Other funds holding MET
VCM
VPM
Amundi's MET Position: Q1 2026 in Review
Amundi reduced its MetLife (MET) stake by 16% in Q1 2026, selling an estimated $37.7M and leaving 2,559,946 shares worth $181M. The position accounts for 0.05% of the portfolio, ranked #300.
Amundi first reported a position in MET in Q2 2021 and has held it in 20 quarters since. The position peaked at $382M in Q3 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Amundi held 2,559,946 shares of MetLife worth $181M as of Q1 2026.
- Amundi sold 503,771 MetLife shares in Q1 2026, an estimated $37.7M.
- MetLife made up 0.05% of Amundi's portfolio in Q1 2026, its #300 holding.
- Amundi first reported a position in MetLife in Q2 2021 and has held it in 20 quarters since.
- Amundi's MetLife position peaked at $382M in Q3 2024.
- 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.